Commonly used blood pressure meds may affect outcomes on COVID-19
Penn Medicine launches an international trial to study whether the medications are beneficial or harmful in the treatment of hospitalized patients.
A new trial led by the Perelman School of Medicinewill evaluate whether the use of medications to treat high blood pressure affect outcomes among patients who are prescribed the medication and hospitalized with COVID-19. As part of the multi-center, international trial called REPLACE COVID, investigators will examine whether ACE inhibitors (ACEI) or Angiotensin Receptor Blockers (ARBs)—two classes of medications to treat high blood pressure—help to mitigate complications or lead to more severe symptoms and worse outcomes. The study is enrolling patients now.
Through the trial, investigators will randomly assign patients who are hospitalized with COVID-19 to either stop or continue taking their prescribed medication. The team will closely monitor the patients to evaluate the effect of temporarily stopping the therapy. Julio A. Chirinos,an associate professor of cardiovascular medicine, and Jordana B. Cohen,an assistant professor in the division of Renal-Electrolyte and Hypertension, are the study’s co-principal investigators.
“While some data suggests patients with underlying health conditions, like heart disease and high blood pressure, have a higher risk of developing a more severe form of COVID-19, we don’t know whether ACE inhibitors or ARBs are beneficial or harmful,” Chirinos says. “There’s an urgent need to understand how these medications may alter the disease course so we can better guide our treatment for patients who are prescribed these therapies and infected with COVID-19.”
People living on small islands and territories face mounting climate impacts, but little is known about their stance on the issue. Research from a team including Parrish Bergquist, assistant professor of political science, aims to fill those gaps.
Penn researchers developed a system that allows light to be guided through a tiny crystal, undeterred by bumps, bends, and back-reflections. Their findings pave the way for robust, controllable light-based chips, smarter routing for data links, and more stable lasers.
A West Philadelphia High School student practices the drum as part of a July summer program in partnership with the Netter Center for Community Partnerships and nonprofit Musicopia.
A summer of student enrichment, from big ideas to bold beats
The Netter Center for Community Partnerships finished its summer of programming for West Philadelphia students, impacting 640 students and six University-Assisted Community Schools.
